International Clinical Trial: A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in patients with systemic sclerosis (SSc)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (PACTR202609848231002) titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in patients with systemic sclerosis (SSc)' on Sept. 11.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using by using procedures such as coin-tossing or dice-rolling,Central randomisation by phone/fax

Primary Sponsor: Boehringer Ingelheim Middle East and North Africa

Condition: Respiratory Respiratory

Intervention: Nerandomilast

Recruitment Status: Not Recruiting

Phase: P...